Corticosteroid therapy's effectiveness in reducing mortality in severe COVID-19 patients is discussed, highlighting ten key reasons underlying its therapeutic benefits and supporting its inclusion in treatment protocols for severe disease management.
May 2021
Predictive modeling studies suggest that strict social distancing measures significantly reduce the probability of contagion, providing valuable insights into the effectiveness of public health interventions in mitigating infectious outbreaks.
May 2021
NYU study provides insights into rates of physical, verbal, and reputational aggression by patients towards practicing dentists, highlighting the need for workplace safety measures and effective communication strategies in dental practice settings.
May 2021
Aerosols, suspended particles capable of airborne transmission, are underestimated in their role in disease spread, highlighting the need for enhanced infection control measures and public health interventions to mitigate aerosol transmission risks.
May 2021
Patients with psychiatric illnesses face increased mortality risk from COVID-19, emphasizing the importance of targeted interventions and integrated mental health care in managing COVID-19 outcomes and reducing mortality rates in vulnerable populations.
May 2021
Systematic review evaluates the impact of clinical pharmacist interventions in type 2 diabetes management, highlighting their role in optimizing medication therapy and improving clinical outcomes for diabetic patients.
May 2021
Refractory gastroesophageal reflux disease presents clinical challenges in symptom management and treatment optimization, highlighting the need for comprehensive evaluation and personalized therapeutic approaches in affected individuals.
May 2021
Post-acute COVID-19 syndrome, characterized by persistent symptoms and complications beyond acute infection, underscores the importance of recognizing and addressing long-term health impacts in COVID-19 survivors, regardless of initial disease severity.
May 2021
One of the largest studies demonstrates the efficacy and safety of electroconvulsive therapy in patients with intractable bipolar disorder, supporting its role as a valuable treatment option in severe and refractory cases.
May 2021
Some individuals continue to experience persistent symptoms and complications, including fatigue, lung damage, and other long COVID symptoms, months after SARS-CoV-2 infection, highlighting the need for ongoing research and clinical management in post-COVID syndrome.
April 2021